Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

Enrolling by invitationOBSERVATIONAL

Enrollment

17,040

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolically Healthy ObesityHyperuricemia

Trial Locations (1)

the First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China, 315000, Ningbo, Zhejiang Province 315000 Recruiting, Ningbo

All Listed Sponsors

lead

Ningbo No. 1 Hospital

OTHER